Brief: Kestra Medical Technologies Inc Q3 EPS USD -0.61
17/03/2026 20:01
Mar 17 (Reuters) - Kestra Medical Technologies Inc Q3 adjusted EBITDA USD -21.191 million vs. IBES estimate USD -20.7 million. Q3 income from operations USD -34.765 million Q3 revenue USD 24.552 million vs. IBES estimate USD 22.9 million Q3 gross profit USD 12.906 million outlook FY revenue USD 93 million vs. IBES estimate USD 90.9 million outlook FY revenue growth 55%
Recent news on Kestra Medical Technologies
See all newsKestra Medical Technologies, Ltd. reports results for the quarter ended April 30 - Earnings Summary
Kestra Medical Technologies Q1 revenue beats estimates, raises FY revenue outlook
Brief: Kestra Medical Technologies Inc Q1 EPS USD -0.75
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
Kestra Medical Technologies Ltd reports results for the quarter ended April 30 - Earnings Summary